Recent IPO Abpro Corporation recently went public with a $69 million IPO, showcasing potential financial stability and investment in clinical trials for cancer and vascular eye disease treatments.
Partnership Expansion Abpro's strategic partnership with Celltrion Group for cancer treatment development presents a collaboration opportunity for sales teams to explore joint projects in the biotech sector.
Bispecific Antibody Development The development of multiple novel bispecific antibody therapies by Abpro in immuno-oncology signals a growing portfolio that could attract partnerships for sales and distribution.
Key Personnel Movement Gavin MacBeath's departure as Chief Scientific Officer creates an opening for potential collaborations or recruitment efforts by sales teams looking to engage with experienced biotech professionals.
Market Expansion in Asia Abpro's collaboration with NJCTTQ from China for bispecific antibody development opens doors for potential market expansion in Asia, offering sales opportunities in the region's burgeoning biopharmaceutical sector.
2.6K
$1B
2.9K$1B
73K$1B
66
5K$1B
512$50M$100M
283$50M$100M
565$100M$1B
201$50M$100MAbpro uses 8 technology products and services including WordPress, Microsoft Word, Microsoft Excel, and more. Explore Abpro 's tech stack below.
| Abpro Email Formats | Percentage |
| FLast@abpro.com | 49% |
| First@abpro.com | 1% |
| FLast@abpro.com | 49% |
| First@abpro.com | 1% |
Biotechnology ResearchMassachusetts, United States11-50 Employees
We're a biotech company dedicated to advancing antibody therapeutics for severe diseases. Focusing on immuno-oncology and ophthalmology, we leverage our proprietary DiversImmune® and MultiMab platforms to develop next-gen antibodies. Collaborating with global pharmaceutical and research partners, we're building a robust pipeline of innovative treatments. For more information, please visit https://abpro.com/
Company Overview
Funding & FinancialsAbpro has raised a total of $18M of funding over 3 rounds. Their latest funding round was raised on Jan 27, 2020 in the amount of $18M.
Abpro 's revenue is in the range of $10M
Funding & FinancialsAbpro has raised a total of $18M of funding over 3 rounds. Their latest funding round was raised on Jan 27, 2020 in the amount of $18M.
Abpro 's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com